In s o m e p a t i e n t s w i t h k e t o t i c h y p o g l y c e m i a a r e d u c e d urinary o u t p u t o f c a t e c h o l a m i n e s h a s b e e n r e p o r t e d . E m p l y l n g a d o u b l e i s o t o p e d e r i v a t i v e t e c h n i q u e ( C l i n .
s c i . 1 9 7 3 , 4 5 : 1 6 3 ) plasma adrenaline a n d n o r a d r e n a l i n e w e r e d e t e z i n e d i n SIX c h i l d r e n w i t h k e t o t i c h y p o g l yc e m i a . O n e o f t h e p a t i e n t s h a d e x t e n s i v e b i l a t e r a l adrenal c a l c i f i c a t i o n s . A d r e n a l c o r t i c a l i n s u f f i c i e n c y was e x c l u d e d .
T h e l a s m a a d r e n a l i n e ' --a l u e s ( m e a n v a l u e ,ng/ml ) b e f o r e -d z i n g h y p o g l y c e m i a w e r e : ( A ) i n p a t i e n t s w i t h o u t adrenal c a l c i f i c a t i o n s 0.05-0.10, ( B ) i n one p a t i e n t w i t h a d r e n a l c a l c i f i c a t i o n 0.01-0.04, ( C ) i n h e a l t h y c h i l d r e n ( n = 3 ) 0 . 2 2 -1 . 3 3 , ( D ) i n h e a l t h y a d u l t s ( n = 5 ) 0.09-0.69. T h e p l a s m a n o r a d r e n a l i n e c h a n g e d i n s i g n i f ic a n t l y i n p a t i e n t s and c o n t r o l s . t h e p l a s m a a d r e n a l i n e was o n l y f o u r p e r cent o f t h e e x p e c t e d v a l u e s .
T h e s e p r e l i m i n a r y r e s u l t s s e e m t o i n d i c a t e t h a t i n p atients w i t h k e t o t i c h y p o g l y c e m i a t h e i m m e d i a t e p l a s m a adrenaline r e s p o n s e d u r i n g h y p o g l y c e m i a i s g r e a t l y red u c e d i n p a t i e n t s w i t h as w e l l as w i t h o u t adrenal cal- On ths 5th day the s c a t t e r i n g o f TSH v a l u e s is much srraller and t h e rrrean is lower than a t b i r t h (< 0.031). In agreement w i t h previo u s l y r e p r t e d d a t a we found sewn TSH l e v e l s o f 160 and 5CO U/d i n 2 hypothyroid i n f a n t s younger t h a n 1 m n t h . The strikin: d i f f e r e n c e beedeen t h e s e high TSH v a l u e s and the c o n t r o l v a l u e s observed o n the 5th day a l l m to s u p p r t the v i a that this s c r e e n i n g procedure is r e l i a b l e f o r d e t e c t i n g c o n g e n i t a l kypmTr.
NEONATAL DETECTION OF HYPOTHYROIDISM BY R A D I O -

IMMUNOA~SAY OF THE T~Y R O X I !~
I N THE ELUATE OF DRIED Bi00D.P.Rochiccioli,G.Dutau,F.Sayard and D.Augier. S e r v i c e de MCdecine I n f a n t i l e C , U.E.R.Toulouse-R a n g u e i l . F r a n c e . I n 5 c o n f i r m e d h y p o t h y r o i d i a n s i n f a n t s t h e a v e r a g e is 160 ' 6 0 pg. I n 2 c a s e s of a t h y r e o s i s t h e a v e r a g e i s 8 0 pg. T h i s method was u s e d f o r d e t e c t i o n o f h y p o t h y r o i d i s m i n one thousand o f newbornsby u s i n g s a m p l i n g s o b t a i n e d from t h e p h e n y l c e t o n u r i c d e t e c t i o n c e n t e r . We d e t e c t e d by t h i s way a c a s e of h y p o t h y r o i d i s m which w a s confirmed by t r a d i t i o n a l t e s t s . We hove studied 17 boys and 11 girls (7 pairs of siblings) with goiter over a period of 2-15 yrs. Methods : In all patients, '311-uptoke, PB1I31, CR, SCNKdischarge, PBI, BE1 or Tq, column chromatogroms of radioiodinated aminoacids in serum have been performed ; in some, chromatograms have been done olso in thyroid tissue and urine.
The a s s a y o f T h y r o x i n (T4) h a s been made by radio-immunoassly i n t h e e l u a t e o f a few d r o p s o f blood d e p o s i t e d on a p i e c e o f b l o t t i n
T h i s method seems t o t o t a l l y j u s t i f y i n g a n e o n a t a l d e t e c t i o n o f h y p o t h y r o i d i s m on a b i g s c a l e . GOITER DUE TO CONGENITAL DYSHORMOGENESIS
Based on laboratory data, 5 groups have been formed. Althoughsynthesis of thyroid hormones is blocked in all enzyme defects, the course of the disease is varioble but characteristic for each group : 1) in 7 of 8 children with complete peroxydase defect, brain damage and idiocy developed despite thyroid theropy beginning shortly after birth. 2)4 patients with Pendred s ndrome were euthyroid and hod smoll goiters ; of 2 sisters with the some J i n i c a l picture,one showed the typical 1'3l discharge whereas the other one hod a normal SCNK test.3) 9 patients with coupling defect hod goiters around the age of 2 yrs and continuously increased in size inspite of thyroid therapy. 4) 3 children with dehalogenase defect were born with goiters ; hypothyroidism developed slowly. In 2 of them goiters had disappeared and laboratory and clinical findings become normal without therapy 2 yrs after compulsory iodination of salt in Argentino. 5 ) In 4 children, the enzyme defect wos not established. Goiter and hypothyroidism appeared around 11 months. Thyroid therapy was very successful. l n i v . K i n d e r k l i n i k . T i i b i n e ; e n , P P P P G .
I
month. T h i s i s a r e p o t on 23 s u c h t r e a t m e n t s , -i n 1 4 c a s e s w i t h 7.5 mg Presomen S~) d a i l y , i n 9 c a s e s w i t h 4.5 mg Presomen
'In 9 c a s e s t h e t h e r a p y h a s meanwhile been terminated. A t t h e s t a r t t h e s e g i r l s showed bone a g e s o f 11 t o 14 cm ( 2 = 8,91cm) T h i s growth r a t e was reduced t o 1.9 cm on t h e a v e r a g e f o r t h e f i r s t year.The growth r e d u c t i o n was 7.22 cm i n t h e mean. I n t h e second group,which we t r e a t e d w i t h 4 , 5 mg, we saw f u rt h e r growth between 2,5 and 442 cm w l t h i n t h e f i r s t s i x months under therapy.Hence we recommended t r e a t a e n t w i t h a d a i l y d o s e of 7.5 mg Presomen. S e r i o u s s i d e e f f e c t s were n o t e n c o u n t e r e d u n d e r t h i s dosage. The a l m o s t a b r u p t g r o w t h . s t o p u n d e r Presomen i n s p i t e o f open e p i p h y s e a l l i n e s caused u s t o i n v e s t i g a t e plasma somatomedin l e v e l s and growth hornone. A f t e r 4 t o 6 months o f t r e a t m e n t t h e somatomedin l e v e l s , c a lc u l a t e d a s r a t i o s o f SM b e f o r e and u n d e r t h e r a p y , were d e c r e a s e d t o r a t i o s between 0.65-0.8 w h i l e GH s e c r e t i o n i n c r e a s e d u n d e r t h e r a p y w i t h Presomen. We have previously reported our experience in treating children with sex hormones. A difficulty of that preliminary study was the inaccuracy of bone age (BA) estimation (Greulich ond Pyle) ond of adult height prediction (Bayley and Pinneou). BA was reassessed in an extended series of 40 girls using the Tanner-Whitehouse I I RUS technique and the new regression equations of Tanner for prediction of adult height. All girls were in puberty at start of treotment (BA 212). They were divided into 3 BA-groups (12.1-13, 13.1-14, 14.1-15) ond received ethinylestrodiol 0.3 mg daily and norethisterone for 5-7 days every 4th week. The mean reduction of adult height was 4.6 i 2.4 cm, slightly more (5.8) in the youngest and somewhat less (4.5) in the oldest BAgroup. BA-velocity during the whole treatment period was 1.5 i 0.5yrs per yr in the youngest and 1.1 i 0.4 yrs/yr in the oldest BA-group.
EXCESSIVELY TALL STATURE IN GIRLS, FURTHER EXPE
The individuol variation, however, wos large in all groups. Posttherapeutic amenorrhea of 0.2-0.5 yrs occurred in only 7 patients.
This improved method of analysis confirms the effectiveness of sex hormone treatment in tall girls.
